Aurobindo Pharma Limited
2,531words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
(E), MUMBAI -400 051 To The Corporate Relations Department BSE LIMITED Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804
₹ 7,979
ncial Highlights 4 Key Financial Highlights of the Quarter Revenue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5%
₹ 1,628
ghts 4 Key Financial Highlights of the Quarter Revenue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Busines
₹ 846
Financial Highlights of the Quarter Revenue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highligh
₹ 7,796
hts of the Quarter Revenue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest
₹ 1,566
uarter Revenue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarte
₹ 817
nue EBITDA Net Profit Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarterly revenu
2.3%
Q3FY25 ₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarterly revenue with 8.5% growth YoY (
3.9%
₹ 7,979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarterly revenue with 8.5% growth YoY (exclud
3.5%
979 Cr ₹ 1,628 Cr ₹ 846 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Q-o-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarterly revenue with 8.5% growth YoY (excluding tr
8.5%
-Q growth % 2.3% 3.9% 3.5% 5 Business Highlights – Q3FY25 Highest ever quarterly revenue with 8.5% growth YoY (excluding transient product ~12% YoY) EBITDA margins stood at comfortable levels of 20
12%
hlights – Q3FY25 Highest ever quarterly revenue with 8.5% growth YoY (excluding transient product ~12% YoY) EBITDA margins stood at comfortable levels of 20.4%, after absorbing higher R&D cost of ~₹ 50
Advertisement